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ABSTRACT
Assessment of nanomaterial (NM) induced inflammatory responses has largely relied on rodent
testing via measurement of leukocyte accumulation in target organs. Despite observations that
NMs activate neutrophil driven inflammatory responses in vivo, a limited number of studies
have investigated neutrophil responses to NMs in vitro. We compared responses between the
human neutrophil-like HL-60 cell line and human primary neutrophils following exposure to sil-
ver (Ag), zinc oxide (ZnO), copper oxide (CuO) and titanium dioxide (TiO2) NMs. NM cytotoxicity
and neutrophil activation were assessed by measuring cellular metabolic activity, cytokine pro-
duction, respiratory burst, and release of neutrophil extracellular traps. We observed a similar
pattern of response between HL-60 cells and primary neutrophils, however we report that some
neutrophil functions are compromised in the cell line. Ag NMs were consistently observed to
stimulate neutrophil activation, with CuO NMs inducing similar though weaker responses. TiO2
NMs did not induce a neutrophil response in either cell type. Interestingly, ZnO NMs readily
induced activation of HL-60 cells but did not appear to activate primary cells. Our findings are
relevant to the development of a tiered testing strategy for NM hazard assessment which pro-
motes the use of non-rodent models. Whilst we acknowledge that HL-60 cells may not be a per-
fect substitute for primary cells and require further investigation regarding their ability to
predict neutrophil activation, we recommend their use for initial screening of NM-induced
inflammation. Primary human neutrophils can then be used for more focused assessments of
neutrophil activation before progressing to in vivo models where necessary.
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Introduction
Materials at the nanoscale often exhibit unique and
beneficial functional properties which are not
apparent in their larger counterparts. This has been
exploited by various industrial and commercial sec-
tors, and the manufacture of engineered nanomate-
rials (NMs) with tunable physicochemical
characteristics has seen rapid growth in recent
years. However, the novel, size-dependent proper-
ties of NMs raise concerns regarding their potential
risk to human health and the environment.
Evidence linking carbon particles found in air
pollution with adverse health effects in humans
demonstrates that nanomaterials emitted by
anthropogenic activities have the potential to be
toxic (Seaton et al. 1995). Negative effects resulting
from human exposure to engineered NMs have also
been reported, for instance inhalation of zinc oxide
NMs induces airway inflammation in healthy human
volunteers (Monse et al. 2019). With the expanding
nanotechnology industry, occupational and environ-
mental incidences of human NM exposure are on
the rise. As such, there is an urgent need to devise
testing strategies that allow for the rapid and reli-
able screening of NM safety.
It is well established that inflammation is one of
the key mechanisms underlying NM toxicity.
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Multiple in vivo rodent studies have used assess-
ment of the infiltration of immune cells, such as
neutrophils, into the target site of interest (e.g.
lungs, liver) as an indicator of NM toxicity (Ma-Hock
et al. 2009; Smulders et al. 2014; Gosens et al.
2015). Neutrophils are part of the front-line of host
defence against intruding pathogens and foreign
bodies and perform a multitude of protective func-
tions including phagocytosis, degranulation, respira-
tory burst response, cytokine production, and the
release of neutrophil extracellular traps (NETs)
(reviewed by Johnston et al. 2018). However, whilst
activation of neutrophils is a normal physiological
response to foreign bodies and pathogens, exces-
sive, prolonged neutrophil activation has the poten-
tial to inflict tissue damage.
While in vivo experiments provide a holistic
understanding of the toxicity of NMs, in vitro meth-
ods allow for detailed and controlled mechanistic
studies to be performed at the cellular level.
Furthermore, cheaper and faster cell-based studies
also support the effort to reduce, replace and refine
the use of laboratory animals; the optimization and
promotion of in vitro techniques should contribute
toward the 3Rs principal (Russell and Burch 2005).
Whilst several in vitro studies have investigated neu-
trophil responses, most of these have typically
relied on the use of primary human cells and inves-
tigated a limited number of NMs and endpoints. As
part of the effort to promote the more widespread
adoption of alternative, non-rodent models for the
study of NM toxicity, we compare the response of
two in vitro neutrophil cell models to a panel of
NMs: primary human blood neutrophils, and differ-
entiated cells from the neutrophil-like HL-60
cell line.
Primary human neutrophils are practically chal-
lenging to work with owing to their short lifespan,
health and safety concerns surrounding the use of
human blood, susceptibility to priming and activa-
tion during isolation, and results that are typically
subject to a high degree of inter-donor variability
(Dransfield and Rossi 2004; Rossi, Ward, and
Dransfield 2004). The use of immortalized HL-60
cells can overcome these issues; however, as a
transformed cell line they may respond differently
to primary human cells. The aim of this study was
therefore to compare and validate responses
between the HL-60 cell line and primary human
neutrophils to identify the benefits and limitations
of each model for nanotoxicology studies.
In the present study, primary human neutrophils
and differentiated HL-60 cells were exposed to sil-
ver (Ag), zinc oxide (ZnO), copper oxide (CuO), and
titanium dioxide (TiO2) NMs, and concentration-
dependent responses measured for a selection of
functions that are indicative of neutrophil activa-
tion. In the first instance, the impact of NMs on cell
metabolic activity was used to rank NM toxicity,
and to determine sub-lethal NM concentrations for
which to study additional neutrophil responses. We
then investigated the release of selected cytokines
(interleukin (IL)-8, macrophage chemotactic protein
(MCP)-1, growth regulated oncogene alpha (GRO-a),
IL-1 receptor antagonist (IL-1Ra) in response to NM
exposure. Cytokines are signaling proteins, some of
which can be released by activated neutrophils dur-
ing inflammation, and play a crucial role in modu-
lating the inflammatory response (Tecchio,
Micheletti, and Cassatella 2014; Tamassia et al.
2018). IL-8, MCP-1, and Gro-a are chemotactic cyto-
kines that are primarily involved in the activation
and recruitment of cell populations (e.g. neutro-
phils, macrophages) to the site of inflammation,
while IL-1Ra inhibits pro-inflammatory activity of IL-
1 cytokines and is therefore involved in dampening
and resolving the inflammatory response. Activation
of a respiratory burst and the generation of reactive
oxygen species (ROS) is a hallmark of neutrophil
activation, and we therefore measured the extracel-
lular release of superoxide anion (O2
) following
NM exposure. The release of NETs is a process in
which activated neutrophils eject web-like struc-
tures comprised of DNA, histones, and granular
antimicrobial proteins, designed to trap and destroy
extracellular pathogens. This novel form of pro-
grammed cell death termed NETosis is a relatively
recent discovery in the field of neutrophil biology,
yet there is already emerging evidence to show
that NET release plays a role in NM-mediated
inflammation (Yang et al. 2019). Given that litera-
ture regarding NM-induced NETosis is limited, we
also explored the capacity of the investigated NM
panel to trigger NET release in vitro, as this informa-
tion may inform screening strategies for neutrophil
responses to NMs in the future. NET formation by
HL-60 cells is more challenging to investigate due
to their suspension nature, and thus only the
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response of primary cells was explored. Finally, to
compare the phagocytic function between HL-60
cells and primary neutrophils, we investigated the
uptake of fluorescently labeled NMs.
We hypothesize that we will observe a similar
pattern of NM-induced toxicity and neutrophil acti-
vation in our in vitro models as has been reported
by in vivo rodent studies of neutrophilic inflamma-
tion following NM exposure. It is envisioned that
our findings will inform model and endpoint selec-
tion for future studies which investigate neutrophil
responses to NMs in vitro as part of a tiered test-
ing strategy.
Materials and methods
All materials were purchased from Sigma-Aldrich
(Poole, UK), unless stated otherwise.
Preparation of NM suspensions
A panel of NMs with different physico-chemical
characteristics was selected for investigation. Ag
(NM-300K), ZnO (NM-110), and TiO2 (NM-105) NMs
were sourced from the Joint Research Center (JRC)
nanomaterials repository1 and supplied by the
Fraunhofer Institute (Munich, Germany). CuO NMs
from Plasma Chem (Berlin, Germany) were kindly
gifted from the Sustainable Nanotechnologies (SUN)
EU project. All NMs were supplied as powders, with
the exception of Ag which was supplied as a
10.16% w/w aqueous dispersion containing stabiliz-
ing agents (4% glycerol trioleate and 4% Tween 20).
The physico-chemical properties of the selected
NMs have been reported previously and are sum-
marized in Table 1.
NMs were prepared using the dispersion protocol
devised as part of the ENPRA project (Jacobsen
et al. 2010). Briefly, NMs were made up as 1mg/mL
suspensions in 2% fetal calf serum (FCS) in sterile
H2O. Samples were vortexed, sonicated for 16min
in an ultrasonic bath, and placed on ice. NMs were
then diluted to the required concentrations in com-
plete cell culture medium and used immediately.
HL-60 cell culture
The human acute myeloid leukemia suspension cell
line, HL-60, was used as a neutrophil model. HL-60
cells were cultured in culture medium (RPMI 1640
containing 2mmol/L L-glutamine, 100U/mol penicil-
lin streptomycin) supplemented with 10% heat-inac-
tivated FCS, and maintained at 37 C in an
atmosphere of 5% CO2. Cells were differentiated to
a neutrophil-like phenotype by incubating with
1 mM all-trans-retinoic acid for 48 h at a density of
2 105 cells/mL, as previously described (Brown
et al. 2010). In preparation for assays, differentiated
HL-60 cells (dHL-60) were seeded in multi-well
plates and incubated for 1 h prior to treatment to
allow cells to settle at the bottom of the wells. All
dHL-60 cell incubations were performed at 37 C in
5% CO2, unless stated otherwise.
Isolation of primary neutrophils from
human blood
Neutrophils were obtained from human blood
donated by consenting, healthy volunteers, con-
ducted in accordance with, and approved by, the
Research Ethics Committee of Heriot-Watt
University (Edinburgh, UK). Peripheral blood was
drawn from the antecubital vein of donors and col-
lected into tubes containing 3.8% sodium citrate to
prevent coagulation. Neutrophils were isolated
using the percoll density gradient centrifugation
method, as described previously (Haslett et al.
1985). Cytocentrifuge preparations of harvested leu-
kocytes were stained with Diff-Quik (Rapid
Romanowsky stain) for the morphological assess-
ment of neutrophil purity, and only populations
containing  95% neutrophils were used. From this
Table 1. Characteristics of the investigated NM panel.
NM Supplier (I.D.) Particle size (TEM) Surface area (BET), m2/g Additional Information References
Ag JRC (NM-300K) <20 nm N/A Klein et al. (2011); Kermanizadeh et al. (2013)
ZnO JRC (NM-110) 100 nm 12 Uncoated Singh et al. (2011); Kermanizadeh et al. (2013)
TiO2 JRC (NM-105) 15–24 nm 46 Anatase Kermanizadeh et al. (2013)
CuO Plasma Chem 15–20 nm 47 Gosens et al. (2016)
Physio-chemical characteristics of NMs according to the supplier are summarized. The NM panel has been characterized extensively in the published lit-
erature, and references containing the detailed characterizations are provided. TEM: transmission electron microscopy; BET: Brunauer–Emmett–Teller. Ag
NMs were supplied as suspension and were therefore not suitable for BET analysis.
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point forward, neutrophils isolated from human
blood will be referred to as primary neutrophils. In
preparation for assays, primary neutrophils were
seeded in multi-well plates in serum-free culture
medium (RPMI 1640 containing 2mmol/L L-glutam-
ine and 100U/mol penicillin streptomycin) and incu-
bated for 1 h at 37 C in 5% CO2 to allow cell
adhesion. Unless stated otherwise, all subsequent
incubations with neutrophils were performed using
cell culture medium containing 10% autologous
donor serum, at 37 C and 5% CO2.
Cell metabolic activity
dHL-60 cells and freshly isolated primary neutrophils
were seeded in 96-well plates at a density of 1 105
cells/well (50mL/well). NMs were added to wells
(50 mL/well) at final concentrations ranging between
0.98 and 125 mg/mL. Untreated, negative control cells
were incubated with culture medium only, and cells
treated with Triton X-100 (0.1%) were included as a
positive control for cell death. Cells were exposed to
treatments for 20 h, after which time the superna-
tants were removed and reserved for subsequent
analysis (stored at 80 C). Cells were washed in PBS,
and cellular metabolic activity assessed using the
alamarBlue assay; a 0.01mg/mL resazurin solution
was prepared in cell culture medium and added to
cells at a volume of 100mL/well. Following incubation
for 3.5 h, supernatants were transferred to a fresh 96-
well plate and fluorescence intensity measured on a
Tecan Spark microplate reader (560/590 nm excita-
tion/emission wavelength). Cellular metabolic activity
was expressed as a percentage of the negative,
untreated control cells. In subsequent assays, NMs
were tested at a range of sub-lethal concentrations
centered around the inhibitory concentration 20%
(IC20, the concentration required to reduce the meta-
bolic activity of cells by 20%). NMs that did not
impact metabolic activity (TiO2 in both cell types,
ZnO in primary neutrophils) were tested at the upper
end of the original concentration range i.e. up to
125 mg/mL.
Assessment of cell morphology using
light microscopy
The morphology of dHL-60 cells and primary neu-
trophils was assessed using light microscopy
following exposure to Ag, CuO, TiO2 and ZnO NMs.
Primary neutrophils were adhered onto glass cover-
slips in 24-well plates at a density of 5.8 105 cells/
well, and exposed to NMs for 4 h at a range of con-
centrations based on their individual IC20 values.
Cells were then washed with PBS, fixed and stained
using Diff-Quik, and finally mounted onto glass
slides using dibutylphthalate polystyrene xylene
(DPX) mounting medium, ready for imaging. dHL-60
cells in suspension do not adhere to glass or plastic
surfaces and were therefore added to 24-well plates
without coverslips and treated as described for pri-
mary neutrophils. Following treatment and washing,
dHL-60 cells were cytocentrifuged onto slides,
stained with Diff-Quik, and sealed with coverslips
using DPX mounting medium ready for imaging.
Cytokine production
GRO-a, MCP-1, IL-8 and IL-1Ra cytokines were meas-
ured in the cell supernatants generated by the
metabolic activity assays (20 h post-exposure to
NMs), using Bio-Plex human cytokine kits in accord-
ance with manufacturer guidelines (Bio-Rad,
Hercules, CA, USA). As a positive control, cells were
exposed to 0.1mg/mL phorbol 12-myristate 13-acet-
ate (PMA), and negative control cells were exposed
to cell culture medium only. Cytokine levels were
measured on a Bio-Plex MAGPIX multiplex reader,
and expressed in pg/mL.
Extracellular superoxide anion production
The extracellular release of superoxide anions (O2
)
was measured using the cytochrome C reduction
assay as previously described (Johnston et al. 2015).
A reaction mixture containing cytochrome C, D-glu-
cose and PBS was freshly prepared (1:2:1 ratio) and
kept on ice in the dark prior to use. dHL-60 cells
and primary neutrophils were seeded in 24-well
plates at a density of 5.8 105 cells/well, (50 mL/
well). Ag, ZnO, CuO and TiO2 NMs were added to
wells at selected sub-lethal concentrations (50mL/
well), followed immediately by the addition of
900 ml reaction mixture to each well (final ratio of
medium:NMs:reaction mix of 1:1:18). In order to
adjust for any O2
 production by NMs, the assay
was also performed in the absence of cells.
Untreated control cells received reaction mix only,
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and positive control cells were exposed to
0.1 mg/mL PMA which is known to stimulate O2

production. To confirm that the assay was measur-
ing O2
 production, an additional control was per-
formed by incubating PMA-treated cells with
superoxide dismutase (SOD): an inhibitor of cyto-
chrome C reduction. Following 2 h exposure, super-
natants were transferred to fresh 96-well plates, and
absorbance measured at 550 nm on a microplate
reader. The level of cytochrome C reduction was
calculated by subtracting the absorbance measured
in the presence of cells from that in their absence,
and data expressed as nMoles of O2
 production
using a molar extinction coefficient for cytochrome
C of 21.1mM1cm1. CuO NMs were found to inter-
fere with reagents of this assay and were therefore
not included in the analysis.
Cellular uptake of fluorescent beads
The uptake of fluorescently labeled latex beads was
used to determine whether dHL-60 cells and pri-
mary neutrophils varied in their ability to internalize
NMs. Primary neutrophils were seeded in optical
bottom 96-well plates at a density of 1 105 cells/
well, and incubated with 0.1mm red fluorescent
carboxylate-modified microspheres (FluoSpheresTM,
580/605 nm excitation/emission; ThermoFisher
Scientific, Waltham, MA, USA) for 2 h. dHL-60 cells
in suspension were incubated with microspheres in
regular 96-well plates under the same conditions,
and subsequently cytocentrifuged onto glass slides
in preparation for counterstaining. Primary neutro-
phils and dHL-60 cells were then washed in PBS
and fixed overnight in 4% methanol-free parafor-
maldehyde (PFA) at 4 C. Following fixation, cells
were washed, permeabilized for 10min using 0.1%
Triton X-100 and washed again. Cells were then
incubated with fluorescein isothiocyanate (FITC)-
conjugated phalloidin for 30min at room tempera-
ture for cytoplasmic actin staining. After a final
wash step, cells were sealed with ProLong Diamond
mounting medium formulated with DAPI (40, 6-dia-
midino-2-phenylindole) for DNA staining. Z-stacks
through cells were acquired on an Andor
Revolution XDi spinning disk confocal microscope
using a 100 oil immersion objective (Olympus,
Tokyo, Japan). 405 nm (diode), 488 nm (Argon) and
561 nm (HeNe) laser lines were used to excite DAPI,
FITC, and the fluorescently labeled NMs respect-
ively, and images captured on an Andor
EMCCD camera.
Neutrophil extracellular trap formation
Neutrophil Extracellular Trap (NET) release in
response to NM exposure was visualized in primary
neutrophils using antibodies directed against neu-
trophil elastase, a primary component of NETs. As a
suspension cell line, dHL-60 cells require cytocentri-
fugation to adhere to glass surfaces. Since this pro-
cess is likely to destroy NETs that may have formed
during NM exposure, it was not possible to visualize
NET release in this cell line using the meth-
ods described.
Primary neutrophils were seeded in optical glass-
bottom 96-well plates at a density of 1 105 cells/
well and exposed to Ag, ZnO, CuO and TiO2 NMs at
a range of concentrations (31.25–125 mg/ml) for 2, 4
and 6 h, as previously described. All subsequent
incubation and wash steps were performed gently
to avoid damage to any NETs that had been
released during NM exposure. Cells were washed in
PBS and fixed overnight in 4% PFA at 4 C.
Following a PBS wash, cells were blocked for 30min
in UltraCruz blocking reagent (Santa Cruz
Biotechnology, Dallas, TX, USA), and incubated with
neutrophil elastase primary antibodies (1:100 dilu-
tion, mouse monoclonal IgG1; Santa Cruz
Biotechnology) overnight at 4 C. Cells were then
washed and incubated with FITC-conjugated sec-
ondary antibodies (1:200 dilution, mouse IgGR BP-
FITC; Santa Cruz Biotechnology) for 1 h at room
temperature. Cells were given a final wash and
sealed with ProLong Diamond mounting medium
containing DAPI for DNA staining. Confocal z-stacks
through cells were acquired on spinning disk con-
focal microscope using a 100 oil immersion
objective and presented as maximum-intensity
projections.
Data analysis and presentation
All results are presented as mean values determined
from a minimum of 3 biological replicates, ± the
standard error of the mean (SEM). All experiments
were performed in triplicate and repeated on at
least three separate days. Statistical analysis was
NANOTOXICOLOGY 5
performed using GraphPad Prism 5, and details are
provided in the figure legends for individual experi-
ments. Significance was set at p< 0.05.
Results
Impact of NMs on the metabolic activity of dHL-
60 cells and primary neutrophils
We compared the metabolic activity of dHL-60 cells
and primary neutrophils following a 20 h exposure
to a panel of NMs (Ag, ZnO, TiO2, CuO) at concen-
trations ranging between 0.98 and 125 mg/mL. A
decline in the mitochondrial metabolic activity of
cells is indicative of reduced cell viability. Therefore,
the measured metabolic activity of treated cells was
expressed as a percentage of untreated controls
and used as a proxy for cell viability. Results are
shown in Figure 1.
Exposure to Ag NMs had a significant impact on
the metabolic activity of dHL-60 cells and primary
neutrophils, with concentrations over 62.5 mg/mL
resulting in complete cell death in both cell types
(Figure 1(A)). dHL-60 metabolic activity was also
impacted by ZnO NMs and reduced to 35% at a
concentration of 15.6 mg/mL. Complete cell
death was observed at ZnO NM concentrations
62.5mg/mL. In contrast, primary neutrophil meta-
bolic activity was not reduced by exposure to ZnO
NMs (Figure 1(B)). CuO NMs were found to reduce
the metabolic activity of both cell types in a con-
centration-dependent manner, though primary neu-
trophils were more sensitive to the effects of
exposure, as shown in Figure 1(C). For example at a
concentration of 62.5mg/mL CuO NMs reduced
metabolic activity to 13% for primary neutrophils
versus 59% in dHL-60 cells. TiO2 NMs had no effect
on the metabolic activity of either cell type at the
concentrations tested (Figure 1(D)).
Given the short lifespan of primary neutrophils in
culture (>50% apoptotic cell death following 20 h
in culture; Taylor et al. 2007), it is important to note
that a high proportion of primary cells in the
untreated control group will have undergone apop-
tosis following the 20 h assay duration. Shorter
time-points (e.g. 12 h) were not compatible with
this assay due to practical considerations, specific-
ally the cumulative time required for neutrophil iso-
lation, NM incubation and alamarBlue treatment. In
light of this, cell morphology was visualized 4 h
post-exposure to NMs to confirm the findings of
metabolic activity assays and further assess impacts
of NMs on cell viability. Results are shown in Figure
1(E). In dHL-60 cells, exposure to Ag, ZnO and CuO
NMs resulted in a loss of cells compared with
untreated controls, which is indicative of cell death.
For these treatments the majority of remaining
viable cells showed signs of damage. TiO2 NMs did
not affect the number or morphology of dHL-60
cells. Primary neutrophils exposed to Ag NMs
showed severe morphological changes, and the
appearance of DNA in the extracellular environment
suggests that these NMs may stimulate NET release.
The remaining treatments did not affect the num-
ber of primary neutrophils or their morphology.
The inhibitory concentration 50% (IC50, the con-
centration required to reduce the metabolic activity
of cells by 50%) was determined for each NM, and
used to rank the toxicity of the NM panel for both
cell types (Figure 1(F)). With the exception of ZnO
NMs the overall ranking of NM toxicity was compar-
able in both cell types (Figure 1(F)), though primary
neutrophils were typically more sensitive to the
effects of NM exposure i.e. they responded to lower
NM concentrations than dHL-60 cells. Accordingly,
for both cell types, Ag and CuO NMs were found to
be toxic, whilst TiO2 NMs were nontoxic. ZnO NMs
were toxic to the cell line but not the primary cells.
Data from cell metabolic activity assays were used
to calculate sub-lethal NM concentrations with
which to investigate responses that are indicative of
neutrophil activation or NM-mediated toxicity to
neutrophils in subsequent assays.
Release of pro- and anti-inflammatory cytokines
by dHL-60 cells and primary neutrophils in
response to NMs
We measured the production of pro-inflammatory
cytokines IL-8, MCP-1 and GRO-a, and the anti-
inflammatory cytokine IL-1Ra by primary neutrophils
and dHL-60 cells exposed to sub-lethal concentra-
tions of Ag, ZnO, CuO and TiO2 NMs for 20 h.
Results are shown in Figure 2. Compared with
untreated controls, there was no change in the pro-
duction of cytokines in either cell type following
exposure to TiO2 NMs. Exposure to Ag and CuO
NMs resulted in a concentration-dependent increase
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Figure 1. Metabolic activity of primary neutrophils and dHL-60 cells following NM exposure. Primary neutrophils (black lines) and
dHL-60 cells (grey lines) were exposed to Ag (A), ZnO (B), CuO (C) and TiO2 (D) NMs for 20 h at concentrations ranging between
0.98lg/mL and 125lg/mL. Untreated control cells were exposed to cell culture medium only. Cellular metabolic activity was
assessed using the alamarBlue assay and expressed as a percentage of the untreated controls (% cell metabolic activity) (n¼ 3–5).
Error bars indicate SEM. Significant differences between dHL-60 cells and primary neutrophils are indicated by p< 0.05,p< 0.01, p< 0.001 (ANOVA followed by post-hoc Bonferroni test). To further assess the impact of Ag, ZnO, CuO and TiO2
NMs on cell viability, the morphology of cells was investigated. Untreated (UT) and NM-treated cells were fixed, stained and
visualized using light microscopy. Representative images are shown of dHL-60 cells (upper panels) and primary neutrophils (lower
panels) following a 4 h exposure to NMs (E). Scale bar ¼ 100mm. IC50 values were calculated and used to rank the toxicity of
NMs for both cell types (F).
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Figure 2. Production of pro-inflammatory cytokines IL-8, MCP-1 and GRO-a, and the anti-inflammatory cytokine IL-1Ra by primary
neutrophils and dHL-60 cells 20 h post-exposure to NMs. dHL-60 cells (left panel) and primary neutrophils (right panel) were
exposed to Ag, ZnO, CuO or TiO2 NMs for 20 h. Untreated (UT) control cells were exposed to cell culture medium only. Cell super-
natants were analyzed for the presence of IL-8 (A), MCP-1 (B), GRO-a (C) and IL-Ra (D) using Bio-Plex human cytokine kits. Data
are expressed as mean cytokine levels of production (pg/mL) (n¼ 3–5). Error bars indicate SEM. Significant differences with
untreated controls are indicated by p< 0.05, p< 0.01, p< 0.001 (ANOVA followed by post-hoc Bonferroni test).
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in the release of pro-inflammatory cytokines in both
dHL-60 cells (IL-8 and MCP-1) and primary neutro-
phils (IL-8 and GRO-a), alongside a concentration-
dependent reduction in the secretion of the anti-
inflammatory IL-1Ra (Figure 2(A–D)). Similarly, ZnO
NMs stimulated a concentration-dependent increase
in the production of IL-8 and MCP-1 by dHL-60 cells
(Figure 2(A,B)), and we also observed an increase in
IL-1Ra levels at ZnO NM concentrations of 7.8 and
15.6 mg/mL (Figure 2(D)). In contrast, we did not
observe any change in the levels of pro- or anti-
inflammatory cytokines released by primary neutro-
phils exposed to ZnO NMs. Gro-a levels in dHL-60
cells (Figure 2(C)) and MCP-1 levels in primary neu-
trophils (Figure 2(B)) were not affected in response
to any of the tested NMs, when compared with
untreated controls.
To ensure cytokine responses observed in pri-
mary neutrophils were not the result of atypical
cells surviving the 20 h experimental duration, cyto-
kine levels were measured following a 6 h exposure
to Ag, ZnO and CuO NMs, revealing a similar pat-
tern of production (Supplementary Figure 1).
NM-mediated activation of respiratory burst in
dHL-60 cells and primary neutrophils
We investigated the respiratory burst response in
dHL-60 cells and primary neutrophils following
exposure to Ag, ZnO, and TiO2 NMs. CuO NMs have
been shown to generate ROS (Angele-Martınez
et al. 2017), and we were unable to distinguish
between superoxide anion (O2
) released by cells
from that produced by the CuO NMs themselves.
Due to this assay interference, CuO NMs were not
included in the analysis. The extracellular release of
O2
 by cells was measured 2 h post-exposure to
sub-lethal NM concentrations. Results are shown in
Figure 3.
The positive PMA control induced a respiratory
burst response in both dHL-60 cells and primary
neutrophils (data not shown). We did not observe
any increase in O2
 release by either primary
neutrophils or dHL-60 cells following a 2 h exposure
to TiO2 or ZnO NMs, when compared with
untreated controls (Figure 3(B,C)). Ag NM exposure
resulted in a concentration-dependent increase in
O2
 production, detectable from 1.3mg/mL in pri-
mary neutrophils and 2.5mg/mL in dHL-60 cells and
peaking at 5 mg/mL in both cell types
(Figure 3(A)).
NET release by primary neutrophils in response to
NM exposure
To determine whether NM exposure resulted in NET
formation, primary neutrophils were treated with
increasing concentrations of Ag, CuO, ZnO and TiO2
NMs, and subsequently stained for nuclear DNA
and the NET-marker neutrophil elastase.
Immunostained cells were then imaged using con-
focal fluorescence microscopy, and identified quali-
tatively as healthy, apoptotic, or NETs which were
further sub-categorized as having either ‘diffuse’ or
‘spread’ morphology (Yan et al. 2012).
Qualitative assessment of primary neutrophils fol-
lowing 4h exposure to Ag NMs revealed a concen-
tration-dependent release of NETs (Figure 4). At the
lowest concentration tested (31.3mg/mL), the major-
ity of neutrophils retained their characteristic multi-
lobed nuclear morphology as seen in untreated con-
trol neutrophils (Figure 4(A)). Upon exposure to Ag
NMs at a concentration of 62.5mg/mL, we observed
the presence of NETs, the majority of which had a
spread morphology. Neutrophils with either intact or
apoptotic nuclei were also observed. All neutrophils
had lost their multi-lobed nuclear structure following
exposure to Ag NMs at a concentration of 93.7mg/
mL and appeared to have formed diffuse NETs. At
the highest tested concentration of 125mg/mL Ag
NMs, NET production was widespread and larger,
aggregate structures had formed. NET production
was quantified in ImageJ based on the neutrophil
elastase signal, which confirmed a concentration-
dependent increase in NET formation in response to
Ag NMs (Figure 4(C)). Time-dependent NET formation
was also observed in response to Ag NMs (47.5mg/
mL) as shown in Figure 4(B) and Supplementary
Figure 2, with the peak of the response observed at
4 h. We did not observe any evidence of NET pro-
duction in primary neutrophils exposed to ZnO, CuO
or TiO2 NMs, at the concentrations and time-points
tested (Figure 4(D)).
NM uptake by primary neutrophils and dHL-
60 cells
To investigate the uptake of NMs by primary neu-
trophils and dHL-60 cells, cells were incubated with
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100 nm fluorescent beads for 2 h, and subsequently
fixed and counterstained for nuclei and cytoplasmic
actin filaments. Cells were imaged by confocal fluor-
escence microscopy and results presented in
Figure 5.
NMs were internalized into the cytoplasm of pri-
mary neutrophils, as shown in Figure 5(A). This was
confirmed by the co-localization of fluorescence sig-
nal from NMs and cytoplasmic actin, which is visible
in the orthogonal projections of confocal z-stacks.
Conversely, we observed minimal uptake of NMs by
differentiated HL-60 cells following a 2 h incubation
(Figure 5(B)).
Discussion
With the increasing ubiquity of NMs in our environ-
ment, it is essential that the generation of
Figure 3. Extracellular superoxide anion production by primary neutrophils and dHL-60 cells 2 h post-exposure to NMs. Primary
neutrophils (left panel) and dHL-60 cells (right panel) were exposed to either Ag (A), ZnO (B) or TiO2 (C) NMs at sub-lethal con-
centrations. O2
 production was measured using the cytochrome C reduction assay. Results are expressed as the average level of
O2
 production (nMoles/mL) (n¼ 3–5). Error bars indicate SEM. Significant differences with untreated (UT) controls are indicated
by p< 0.05, p< 0.01, p< 0.001 (ANOVA followed by post-hoc Bonferroni test).
10 R. VERDON ET AL.
Figure 4. NM-induced release of neutrophil extracellular traps (NETs) in primary neutrophils immunostained for nuclear DAPI
(green) and neutrophil elastase (red). Representative images of primary neutrophils following 4 h exposure to increasing concen-
trations of Ag NMs are presented (A). Fixed and stained cells were imaged using confocal microscopy and qualitatively categorized
as either normal (multi-lobed nuclei), apoptotic (condensed nuclei), or NETs which were further sub-categorized as having either
‘diffuse’ or ‘spread’ morphologies. Examples of neutrophil morphologies are shown. Aggregation of NETs resulting in the formation
of larger structures is visible when primary neutrophils were exposed to 125mg/mL Ag NMs, as indicated by white dashed line.
Primary neutrophils exposed to 46.5mg/mL Ag showed increase NET formation over time (B). Concentration and time-dependent
NET release in primary neutrophils exposed to Ag NMs was quantified based on neutrophil elastase signal and expressed as a
fold-change relative to untreated (UT) controls (n¼ 3–5) (C). Error bars indicate SEM. Significant differences with untreated con-
trols are indicated by p< 0.05, p< 0.01, p< 0.001 (ANOVA followed by post-hoc Dunn’s multiple comparison test). NET
formation was not observed in cells exposed to ZnO, CuO or TiO2 NMs at any of the tested concentrations (31.25–125mg/ml) (D).
Scale bar ¼ 30mm.
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toxicology data regarding NM safety matches the
pace of the developing nanotechnology industry.
To date, numerous studies have demonstrated that
one of the primary mechanisms underlying NM tox-
icity is the activation of inflammatory responses.
Inflammation is our fundamental defence mech-
anism against harmful stimuli, and involves an orch-
estrated response between several different cell
types to protect and restore the site of injury.
Neutrophils are our most abundant circulating leu-
kocytes and are amongst the first responders to
inflammation. Upon activation, neutrophils can elicit
a broad spectrum of functions designed to capture
and neutralize the invading pathogen, such as
phagocytosis, degranulation, respiratory burst
response, cytokine production, and the release of
NETs. However, neutrophils have been described as
the ‘double-edged swords’ of immunity given that
they have the potential to inflict tissue damage if
inflammation is not resolved (Parkos 2016).
Much of our knowledge regarding the inflammo-
genicity of NMs is derived from in vivo rodent stud-
ies, however their ability to predict human effects is
limited due to species differences. Furthermore,
there is a drive within the scientific community to
seek out alternative, non-rodent models to align
toxicology testing with the principles of the 3Rs i.e.
the Replacement, Reduction & Refinement of animal
testing (Russell and Burch 2005; Holmes, Creton,
and Chapman 2010; Burden et al. 2015). Given the
growing number of NMs with diverse physico-
chemical characteristics (e.g. particle size, shape,
charge, surface chemistry and aggregation), the use
of in vitro models is especially appealing as they
offer high-throughput and rapid testing solutions
for the assessment of NM toxicity.
Figure 5. Uptake of 100 nm fluorescently labeled NMs by primary neutrophils and dHL-60 cells. Primary neutrophils (A) and dHL-
60 cells (B) were incubated with 100 nm fluorescent carboxylate-modified NMs (FluoSpheresTM) (red) for 2 h, fixed and counter-
stained with phalloidin (green) and DAPI (blue) for visualization of cell nuclei and cytoplasmic actin respectively. Confocal Z-stacks
were acquired, and orthogonal (XZ and YZ) projections used to confirm the internalization of particles by cells, highlighted by
white arrows. Images shown are representative. Scale bar ¼ 10mm.
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In spite of their pivotal role in inflammation,
research dedicated to the neutrophil response to
NMs in vitro is relatively sparse in contrast with
other cell types such as macrophages (Johnston
et al. 2018; Keshavan et al. 2019). Working with
neutrophil-like cell lines can address many of the
challenges surrounding the use of human primary
neutrophils (e.g. short lifespan, donor pool limita-
tions, ethical concerns), and typically are more
accessible, cost-effective, comparatively easier to
work with and more amenable to high-throughput
testing strategies. However, there are concerns
regarding the physiological relevance of cell lines,
and as such it is important to demonstrate that
they exhibit functional features that resemble the
target cell type as closely as possible. Here, we
compare NM-mediated responses between primary
neutrophils isolated from human blood, and neutro-
phil-like cells derived from the human leukemia HL-
60 cell line, for a selected panel of NMs.
Inflammatory responses by dHL-60 cells and
primary neutrophils to the investigated NM panel
In the first instance, the cytotoxicity of the NM
panel to both cell types was investigated via assess-
ment of changes in metabolic function. Overall, our
data have shown a similar patten of NM toxicity
between primary neutrophils and dHL-60 cells
(Ag>CuO> TiO2), with ZnO NMs being a notable
exception. Similar rankings in the toxicity of these
NMs have been reported by other studies
(Bondarenko et al. 2013; Kermanizadeh et al. 2013;
Smulders et al. 2014; Giovanni et al. 2015; Brzicova
et al. 2019), most frequently of the order
Ag>ZnO>CuO> TiO2.
Though TiO2 has long been considered a bio-
logically inert material with low toxicity, studies
have shown that exposure to TiO2 NMs can elicit
toxic responses such as inflammation, apoptosis,
and oxidative stress (Skocaj et al. 2011; Baranowska-
Wojcik et al. 2020). Of interest to this study is the
fact that increased numbers of neutrophils have
been reported in the bronchoalveolar lavage fluid
(BALF) of rodents following pulmonary exposure to
TiO2 NMs, indicating pulmonary toxicity (Sager,
Kommineni, and Castranova 2008; Ma-Hock et al.
2009). Our results showed that TiO2 NMs did not
have any significant impact on the metabolic
activity of primary neutrophils or dHL-60 cells, and
did not induce pro-inflammatory responses with
respect to cytokine secretion, respiratory burst, or
NET release. These findings align with existing
in vitro studies that have shown TiO2 NMs have no
effect on the viability of human primary neutrophils
(Hedenborg 1988; Gonçalves, Chiasson, and Girard
2010). Further investigation by Gonçalves, Chiasson,
and Girard (2010) revealed that TiO2 NMs in fact
delayed apoptosis of human primary neutrophils;
an effect with potentially harmful consequences
in vivo, if persisting neutrophils release toxic sub-
stances into the surrounding tissue.
Owing to their broad range of applications, Ag
NMs are amongst the most widely used NMs in
commercial and industrial products, and accordingly
many studies have investigated their cytotoxic
potential (Akter et al. 2018). In vivo, Ag NMs have
been reported to cause inflammatory effects in mul-
tiple organs and tissues, including the lung (Arai,
Miyayama, and Hirano 2015; Gan et al. 2020), liver
(Gaiser et al. 2013; Roda et al. 2019), heart (Ferdous
et al. 2019), and brain (Xu et al. 2015). In vitro, the
cytotoxicity of Ag NMs has been largely attributed
to oxidative stress, DNA damage, and pro-inflamma-
tory responses (reviewed by Stensberg et al. 2011;
Kumar, Sharma, and Maitra 2017; Akter et al. 2018;
Cameron, Hosseinian, and Willmore 2018, Johnston
et al. 2018). In the present study, Ag NMs were
overall the most potent inducers of pro-inflamma-
tory responses by primary neutrophils and dHL-60
cells across the endpoints tested, echoing those
findings reported within the literature. Complete
cell death of both cell types occurred at Ag NM
concentrations 62.5mg/mL, and we observed peak
levels of increased superoxide anion production at
a concentration of 5 mg/mL. Elevated secretion of
pro-inflammatory cytokines was accompanied by a
significant decrease in anti-inflammatory IL-1Ra,
indicating that Ag NMs are likely to stimulate a pro-
longed inflammatory response with delayed reso-
lution. Furthermore, within the investigated NM
panel, only Ag NMs were found to trigger NET
release by primary neutrophils. The mechanisms
underlying NET release are still under investigation,
however, our findings would appear to agree with
current knowledge in this field, as it has been
established that NET release is dependent on the
generation of ROS through activation of NADPH
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oxidase, triggered by pro-inflammatory mediators
(Stoiber et al. 2015). Overall, our findings regarding
the pro-inflammatory effects of Ag NMs draw a
strong parallel to those reported by existing in vitro
and in vivo studies.
CuO NMs have been shown to induce pulmonary
inflammation in vivo (Pettibone et al. 2008; Kim
et al. 2011; Gosens et al. 2016), and we observed
pro-inflammatory responses in both primary neutro-
phils and dHL-60 cells following CuO NM exposure,
though responses were less pronounced than those
resulting from Ag NMs. Cellular metabolic activity
was significantly reduced, and primary neutrophils
were notably more sensitive to the effects of expos-
ure. Cytokine analyses revealed increased produc-
tion of pro-inflammatory cytokines and a decrease
in the anti-inflammatory cytokine IL-1Ra. We were
unable to measure superoxide production in cells
exposed to CuO NMs, due to significant assay inter-
ference. Future studies should prioritize alternative
techniques to study extracellular ROS production
such as chemiluminescence assays, or consider
measuring intracellular ROS (Griendling et al. 2016).
In contrast to observations made in Ag NMs, we did
not observe NET release in primary neutrophils
exposed to CuO NMs.
An unexpected result of this study was the strik-
ing difference in ZnO NM-mediated responses
between dHL-60 cells and primary neutrophils. Our
cytotoxicity studies revealed that exposure to ZnO
NMs caused a significant reduction in dHL-60 cell
metabolic activity, though did not appear to impact
the metabolic activity of primary neutrophils at any
of the tested concentrations. While we did not
detect any significant change in cytokine produc-
tion by primary neutrophils, ZnO NMs stimulated
the secretion of pro-inflammatory cytokines IL-8
and MCP-1 by dHL-60 cells. Superoxide anion
release was not affected in either cell type. Our
findings in primary neutrophils are in contrast to
those observed in other cell types where ZnO NMs
have been shown to exert cytotoxic effects driven
by the generation of ROS and/or pro-inflammatory
mediators, for example in hepatocytes
(Kermanizadeh et al. 2013) lung epithelial cells
(Huang et al. 2010; Lai et al. 2015) and macro-
phages (Wilhelmi et al. 2013). There is also ample
in vivo evidence supporting ZnO NM induced
inflammation (reviewed by Singh 2019), such as
neutrophil infiltration in the lungs of exposed ani-
mals (Sayes, Reed, and Warheit 2007; Gosens et al.
2015; Morimoto et al. 2016).
Though literature regarding the impact of ZnO
NMs on human primary immune cells in vitro is lim-
ited, there are studies that have described similar
results to our own. Silva and Girard (2016) reported
that exposure to ZnO NMs (100mg/mL) inhibited
apoptosis of isolated human eosinophils and had
no effect on ROS production, though they did
detect an increase in the release of pro-inflamma-
tory cytokines. Goncalves and Girard (2014) also
observed delayed apoptosis of human primary neu-
trophils in response to ZnO NM exposure, with no
changes in either extracellular superoxide or intra-
cellular ROS production, however changes in
morphology indicated that the cells were in an acti-
vated state. The authors were careful to point out
that this lack of apoptosis did not rule out ZnO
NMs as an agonist of inflammation; on the contrary,
delayed apoptosis and the prolonged presence of
neutrophils could lead to tissue damage as a result
of unresolved inflammation. Within the limited
time-frame investigated in the present study, and
lacking in vivo context, we cannot ascertain whether
the responses observed in primary neutrophils
would ultimately have deleterious effects in vivo.
Reasons as to why the responses of the dHL-60
cells may differ from those of the primary neutro-
phils are explored below, as well as discussion of
the limitations of each cell model.
Differences in responses between dHL-60 cells and
primary neutrophils
Established in 1977 (Collins, Gallo, and Gallagher
1977), the HL-60 cell line was widely employed to
study neutrophil differentiation and migration,
although its use has since been expanded to study
neutrophil functions across a variety of research
fields including NM-mediated inflammatory
responses (Johnston et al. 2015).
Interestingly, several studies have reported sig-
nificant differences between the behavior of HL-60
cells and primary neutrophils. Yaseen et al. (2017)
reported that ROS production and NET release in
response to a bacterial pathogen was markedly
impaired in HL-60 cells compared with primary neu-
trophils. Babatunde et al. (2019) observed
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differences in the chemotactic behavior between
the two cell types, notably that dHL-60 cells
migrated at a slower pace and in smaller groups.
Furthermore, Pelletier, Savoie, and Girard (2000)
have shown that the pollutant Na2SO3 is an inflam-
matory agonist of primary neutrophils, but not to
dHL-60 cells.
Overall, we have found that the pattern of
inflammatory responses between the HL-60 cell line
and primary human neutrophils exposed to our NM
panel was comparable, with the exception of ZnO
NMs. For example, Ag NM-induced inflammatory
responses were characterized by cytotoxicity,
increased production of pro-inflammatory cytokines,
decreased production of anti-inflammatory cyto-
kines, and increased superoxide production.
Meanwhile, TiO2 NMs had no significant impact on
either cell type. However, there remain key differen-
ces in the specificities of each response between
the two cell types e.g. differences in specific cyto-
kines produced, amplitude of response and phago-
cytic function. These differences demonstrate that
HL-60 cells can respond differently to primary neu-
trophils, highlighting limitations of this cell line.
Furthermore, the suspension nature of HL-60 cells
presents additional practical challenges, for instance
we were unable to investigate NET release using
immunofluorescent antibody staining in fixed cells.
We hypothesized that differences in NM-medi-
ated responses may have been at least partly
related to differences in the phagocytic function of
these two cell types i.e. primary neutrophils and
dHL-60 cells may vary in their capacity to internalize
NMs. We therefore investigated the uptake of
100 nm carboxylated fluorescent NMs over a 2 h
incubation period. We found that primary neutro-
phils readily internalized particles in contrast with
minimal uptake by dHL-60 cells. These findings
demonstrate that there may be distinct differences
in NM uptake between the two cell types, and we
propose that the increased sensitivity of primary
neutrophils to NM exposure may arise from
enhanced NM uptake. However, it is important to
note that the phagocytic capability of neutrophils is
influenced by a variety of factors, including particle
size, composition and dispersion medium.
Therefore, further studies should visualize and
quantify the uptake of the tested NM panel, to bet-
ter understand the role of NM uptake in the
observed cellular responses. Bisso et al. (2018) have
investigated the effects of human serum albumin
on NM internalization, reporting that neutrophil
uptake of polystyrene and liposomal NMs was
respectively abolished or reduced in culture
medium containing 10% human serum, whereas
the uptake of poly(lactic-co-glycolic acid) (PLGA)
particles was enhanced. These findings were echoed
by (Kelley et al. 2018) in differentiated HL-60 cells,
observing a significant increase in the uptake of
both PEGylated (polyethylene glycol-conjugated)
and carboxylated NMs in the presence of human
serum, in contrast with conventional culture
medium containing FCS. The use of autologous
human serum in neutrophil cell lines for NM toxicol-
ogy may therefore offer greater physiological rele-
vance, bridging the gap between cell lines and
in vivo systems and should be explored in
the future.
Ultimately, there are limitations of the HL-60 cell
line which may compromise their ability to act as a
substitute for primary cells when assessing neutro-
phil responses to NMs. Accordingly, we have out-
lined below a set of recommendations to guide
future investigations of neutrophil responses in vitro
using these two cell models.
Recommendations for future testing: model and
endpoint selection
It is important to establish where the strengths and
limitations of in vitro models lie to better under-
stand how they can be applied to nanotoxicology
testing. The findings from our study may inform
future testing strategies which assess neutrophil
responses to NMs in vitro, as a guide to both model
and endpoint selection. Furthermore, our research
is potentially relevant to the investigation of a
wider panel of substances and pathogens, and not
limited to the field of nanotoxicology. For future
studies, we propose that the responses of HL-60
cells are screened before proceeding with primary
cells, where a wider range of endpoints that cannot
be investigated in HL-60 cells can be explored.
Below are our recommendations for prioritization
of endpoints.
Firstly, we recommend that the response of HL-
60 cells and primary cells is screened via assess-
ment of cellular metabolic activity, allowing the
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toxic potency of different NMs to be compared and
enabling identification of sub-lethal NM concentra-
tions for subsequent investigation. Assessment of
cytokine production is a common measure of NM
toxicity in vitro, and can be measured in superna-
tants collected during cytotoxicity studies thereby
maximizing the amount of data that can be gath-
ered from a single experiment; this is particularly
attractive when working with primary cells. We
have observed that the types of cytokine released
vary between the two cell types in response to NM
exposure. Specifically, IL-8 production was observed
in both cell types, whereas GRO-a release was only
observed in primary cells and similarly MCP-1 pro-
duction was only detected in HL-60 cells. We there-
fore suggest that assessment of IL-8 production is
prioritized as a marker of cell activation in future
studies of neutrophil responses in vitro. Of benefit
is that throughout the literature, the release of the
pro-inflammatory cytokine IL-8 in response to NM
exposure has consistently been reported in numer-
ous cell types such as macrophages, lung and intes-
tinal epithelial cells, and hepatocytes (Brown et al.
2010; Gaiser et al. 2013; Johnston et al. 2015; Ude
et al. 2017).
Assessment of respiratory burst activation via
measurement of superoxide anion production pro-
vided a rapid assessment of neutrophil activation
by NMs, with results obtained 2 h post-exposure in
both cell types. Whilst primary neutrophils pro-
duced a stronger response, this assay is applicable
to both cell types and can provide a good indica-
tion of cell activation by NMs. However, the assay
we selected was not suitable for CuO NMs due to
problems with NM interference. This issue has been
reported for other NMs and assays (Ong et al.
2014), demonstrating that assessment of NM inter-
ference is a key component of nanotoxicity testing
and ultimately dictates which endpoints are applic-
able in vitro.
We observed Ag-NM induced NET formation in
primary cells in vitro using immunofluorescent anti-
body labeling in fixed cells, however we found this
assay was not reproducible in HL-60 cells due to
their suspension nature (data not shown). Previous
studies have demonstrated NET release by HL-60
cells (Kawakami et al. 2014; Nakayama and Saitoh
2015); therefore, we would propose that future
studies should consider techniques for NET
detection that are compatible in both cell types
such as the use of intravital stains (e.g. Sytox live-
cell exclusion DNA dye, combined cell membrane
permeable/impermeable dyes). These techniques
which use live cells offer the additional benefit of
allowing for visualization of NETosis kinetics.
Whilst in vitro studies may indicate whether NMs
are likely to stimulate a pro-inflammatory response,
it is challenging to determine whether inflammation
is resolved within an in vitro setting. Information
regarding inflammation resolution is critical in the
assessment of NM toxicity, to determine whether
responses are physiological or pathological in
nature. Measurement of the anti-inflammatory cyto-
kine IL-Ra proved useful in identifying NMs that
may hinder the resolution of neutrophilic inflamma-
tion. However, in vivo studies are required to con-
firm the activation of persistent inflammatory
responses by NMs. We have advocated previously
that zebrafish may help bridge the gap between
in vitro and rodent models in nanotoxicology, by
allowing us to explore the activation and resolution
of inflammatory responses following NM exposure
(Johnston et al. 2018).
Conclusion
Despite the prominent role neutrophils play in NM-
induced inflammation in rodents in vivo, it is sur-
prising that only a limited number of studies have
investigated neutrophil responses to NMs in vitro.
Whilst our results indicate that HL-60 cells may not
be a perfect substitute for primary cells and require
further investigation regarding their ability to pre-
dict neutrophil responses, we suggest that in vitro
neutrophil studies of NM exposure are more rou-
tinely used to assess NM safety, and propose the
more widespread use of both the neutrophil-like
HL-60 cell line and primary human neutrophils.
Beyond the present study, a wider panel of NMs
possessing diverse physico-chemical properties
should be tested across both cell models to further
determine whether or not the HL-60 cell line is pre-
dictive of primary human cell responses. However,
based on our current findings we advocate that a
tiered testing strategy incorporating a variety of
model systems is adopted to study neutrophil
responses to NMs. In the first instance, we recom-
mend that the HL-60 cell line is used to screen for
16 R. VERDON ET AL.
various neutrophil functions before progressing
with primary human cells. Regarding the selection
of endpoints, we would advise that cytotoxicity,
cytokine production, and activation of respiratory
burst are considered in both cell types. We propose
that transgenic zebrafish larvae (not protected by
EU legislation up to 5 days post-fertilization) that
allow for direct visualization of neutrophil activity
and inflammatory resolution should be considered
as the next step before progressing to rodent stud-
ies (if deemed necessary). This overall approach will
better align nanotoxicology testing with the
3Rs principles.
Note
1. https://ec.europa.eu/jrc/en/scientific-tool/jrc-
nanomaterials-repository
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